Jasper Therapeutics, Inc.

Ownership Transactions Reported by 24 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	3	+590K	99.5%	$11.91	+$7.02M
Sells	1	-2.7K	0.5%	$23.94	-$64.6K
Net	+2	+587K	99.1%		+$6.96M

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Velan Capital Investment Management LP	10%+ Owner	$18.6M	+$4.53M	+32.3%	Feb 8, 2024
Carlyle Group Inc.	Former 10% Owner	$13.8M	+$2.46M	+21.7%	Feb 8, 2024
Qiming U.S. Healthcare Fund II, L.P.	10%+ Owner	$5.53M			Jan 27, 2023
Roche Holding Ltd	10%+ Owner	$2.95M			Jan 25, 2023
Balaji Venkataraman	Former Director And Officer	$1.49M			Sep 24, 2021
Kenneth F. Clifford	Former Officer	$1.49M			Sep 24, 2021
Amplitude Healthcare Holdings LLC	10%+ Owner	$1.49M			Sep 24, 2021
Howard I. Hoffen	Former Director	$1.49M			Sep 24, 2021
Jeetinder Singh Mahal	Chief Operating Officer	$1.13M	-$64.6K	-5.39%	Sep 12, 2024
Ron Martell	President, CEO and Director, Director	$215K			Jun 10, 2024
William Lis	Director	$34.7K			Oct 13, 2023
Thomas G. Wiggans	Director	$32.4K	+$31.1K	+2355%	Jun 6, 2024
Edwin Jonathan Tucker	Chief Medical Officer	$1.67K			Jun 7, 2024
Abingworth LLP	10%+ Owner				Mar 21, 2022
Chris Nolet	Director				Jun 6, 2024
Scott C. Brun	Director				Jun 6, 2024
Lawrence Klein	Director				Jun 7, 2023
Anna Louise French	Director				Jun 6, 2024
Judith Anne Shizuru	Director				Jun 6, 2024
Vishal Kapoor	Director				Jun 6, 2024
Herb Cross	Chief Financial Officer				Feb 15, 2024
Kurt Von Emster	Director				Jun 6, 2024
Kevin N. Heller	Executive Vice President, Research and Development				Mar 21, 2022
Svetlana Lucas	Director				Jun 18, 2024

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.